Status:
COMPLETED
Interest of the Donor-specific Antibodies After Liver Transplantation
Lead Sponsor:
University Hospital, Lille
Conditions:
Liver Transplant
Eligibility:
All Genders
18+ years
Brief Summary
The study is a prospective observational mono center study Primary objective : Study the anti-HLA antibodies frequency preformed before liver transplantation and the kinetic of appearance of DSA and...
Eligibility Criteria
Inclusion
- Liver transplanted patients older than 18, transplanted in Lille University Hospital.
- Written consent by the patient or his/her legal representative (especially patient with hepatic encephalopathy).
- Patients with health insurance
Exclusion
- Minor patients.
- Pregnant women or during lactation.
- Patient under curatorship.
Key Trial Info
Start Date :
February 16 2016
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
July 13 2019
Estimated Enrollment :
120 Patients enrolled
Trial Details
Trial ID
NCT03238443
Start Date
February 16 2016
End Date
July 13 2019
Last Update
March 25 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
CHRU, Hôpital Claude Huriez
Lille, France